<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Prognosis on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/prognosis/</link><description>Recent content in Prognosis on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Wed, 01 Jul 2026 05:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/prognosis/index.xml" rel="self" type="application/rss+xml"/><item><title>Joint Involvement Pattern Predicts Treatment Response in Early RA</title><link>https://rheumatologydigest.org/posts/joint-pattern-ra-treatment-response/</link><pubDate>Wed, 01 Jul 2026 05:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/joint-pattern-ra-treatment-response/</guid><description>A combined individual-patient-data analysis of the NORD-STAR and BeSt trials shows that where early RA is distributed carries prognostic signal: hand-dominant disease (JIP-Hand) predicts better treatment response and polyarthritis (JIP-Poly) worse — independent of sex and serology, and equally across csDMARDs and bDMARDs, with ACPA/RF showing no association with short-term activity response.</description></item></channel></rss>